Haohai Biotech: Shareholder and one of the actual controllers Jiang Wei received a "Decision on Release on Bail pending Trial" for non-company matters.

Haohai Life Sciences announced that the company recently received a notice from Mr. Jiang Wei, one of the controlling shareholders and actual controllers, who is suspected of insider trading and is currently under investigation. The Shanghai Public Security Bureau issued a "Release Pending Trial Decision" for Mr. Jiang Wei, with the period starting from April 29, 2026. Previously, Mr. Jiang Wei had received an "Administrative Penalty Decision" from the China Securities Regulatory Commission in December 2025 for insider trading and other activities. The above-mentioned matters are unrelated to the company, as Mr. Jiang Wei does not hold any position as a director, senior management, or any other role in the company. This matter will not have a significant impact on the company's daily operations.